share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

SEC announcement ·  Jun 14 04:15
Summary by Futu AI
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 12, 2024. The transaction was carried out in the open market with the shares sold at a price of $478.00 each, resulting in a total sale value of $1,089,840. Following the sale, Bozic's direct holdings in the company amount to 32,379 shares of common stock.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 12, 2024. The transaction was carried out in the open market with the shares sold at a price of $478.00 each, resulting in a total sale value of $1,089,840. Following the sale, Bozic's direct holdings in the company amount to 32,379 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.